Organization
Hospital Germans Trias i Pujol
6 abstracts
Abstract
First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM).Org: Sackler School of Medicine, Hospital Universitario Fundación Jiménez Díaz, McGill University and MUHC, Sungkyunkwan University School of Medicine, Hospital Germans Trias i Pujol,
Abstract
Bromodomain and extra-terminal (BET) inhibitor INCB057643 (LIMBER-103) in patients (pts) with relapsed or refractory myelofibrosis (R/R MF) and other advanced myeloid neoplasms: A phase 1 study.Org: Sylvester Cancer Center, Emory University School of Medicine, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hospital Germans Trias i Pujol, Institut Català D'Oncologia,
Abstract
New ESMO scale for clinical actionability of molecular targets (ESCAT) for gliomas based on a multicentric real world data cohort using next-generation sequencing (NGS).Org: Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain, Hospital Universitario 12 de Octubre, Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d´Hebron Institute of Oncology (VHIO), Institut Catala d'Oncologia Badalona,
Abstract
Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.Org: Catalan Institute of Oncology-Hospitalet, Hospital Josep Trueta, IDIBGi, Hospital Germans Trias i Pujol, IGTP (Health Research Institute Germans Trias i Pujol),
Abstract
ANTIMALARIAL MYOPATHY: PREVALENCE AND CLINICAL FEATURRESOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Neurology Department, Corporació Parc Taulí, Sabadell, Pathology Deparment,
Abstract
ASSOCIATION BETWEEN DISEASE ACTIVITY AND DAMAGE IN IDIOPATHIC INFLAMMATORY MYOPATHIES. DIFFERENCES BETWEEN INCIDENT AND PREVALENT CASESOrg: Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Unidad de Investigación, Sociedad Española de Reumatología, Madrid, Spain, Hospital del Mar, Barcelona, Spain,